TMCnet News
Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2016 - Research and MarketsResearch and Markets has announced the addition of the "Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2016" report to their offering. This report provides comprehensive information on the therapeutic development for Microscopic Polyangiitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Microscopic Polyangiitis and special features on late-stage and discontinued projects. The report enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-classand best-in-class products. Key Topics Covered:
For more information about this report visit http://www.researchandmarkets.com/research/jrtb76/microscopic Related Topics: Cardiovascular Drugs
View source version on businesswire.com: http://www.businesswire.com/news/home/20160831005813/en/ |